ANW:FRA
Immuron Ltd
0,030 €
0,00%
(0,00) 1 p
12. okt, 08:05:52 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ANW põhistatistika genereerimine…
Turu kapit.
12,20 mln
Keskm. maht
627,00
Maht
0,00
52 näd kõrgeim
0,04 €
52 näd madalaim
0,01 €
Töötajate arv
8
Turu kapit.
12,20 mln
Keskm. maht
627,00
Maht
0,00
52 näd kõrgeim
0,04 €
52 näd madalaim
0,01 €
Töötajate arv
8
Uudised
Veebiallikatest ja uudistepartneritelt
TipRanks
·
6 tunni eest
Immuron advances Travelan after Phase 2 data published in Nature journal
https://www.dars.gov.et/
·
1 nädala eest
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
Profiil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Teave üksuse Immuron Ltd kohta
Tegevjuht-
Töötajad8
Asutatud1994
PeakontoridBlackburn North, Victoria, Austraalia
Sektor-
Veebisaitimmuron.com.au